Geron Corporation (GERN) saw a big move last session, as the company’s shares plunged by nearly 62% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for GERN, as the stock is now down nearly 67% since Feb 27.
This company in Healthcare sector has seen a flat track record when it comes to current year estimate revisions over the past few weeks. The consensus for earnings hasn’t changed either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.
GERN currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the same space include Alexion Pharmaqceuticals, Inc. (ALXN), Alkermes plc (ALKS) and Gilead Sciences Inc. (GILD). All these stocks carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
GERON CP (GERN): Free Stock Analysis Report
ALEXION PHARMACEUTICALS INC (ALXN): Free Stock Analysis Report
ALKERMES PLC ORD (ALKS): Free Stock Analysis Report
GILEAD SCIENCES INC (GILD): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Health Care Industry
- Geron Corporation